Genetic Testing is Superior Over Endogenous Pharmacometabolomic Markers to Predict Safety of Haloperidol in Patients with Alcohol-induced Psychotic Disorder

dc.contributor.author	Lauschke, Volker M.
dc.date.accessioned	2023-12-20T11:37:59Z
dc.date.available	2023-12-20T11:37:59Z
dc.date.issued	2022
dc.identifier.issn	1389-2002
dc.identifier.uri	http://hdl.handle.net/10900/148773
dc.language.iso	en	en
dc.publisher	Sharjah : Bentham Science Publ Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.2174/1389200224666221228112643
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Genetic Testing is Superior Over Endogenous Pharmacometabolomic Markers to Predict Safety of Haloperidol in Patients with Alcohol-induced Psychotic Disorder	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230925000000_05780
utue.publikation.seiten	1067-1071	de_DE
utue.personen.roh	Skryabin, Valentin
utue.personen.roh	Zastrozhin, Mikhail
utue.personen.roh	Parkhomenko, Alexandra
utue.personen.roh	Lauschke, Volker M.
utue.personen.roh	Smirnov, Valery
utue.personen.roh	Petukhov, Aleksey
utue.personen.roh	Pankratenko, Elena
utue.personen.roh	Pozdnyakov, Sergei
utue.personen.roh	Koporov, Sergei
utue.personen.roh	Denisenko, Natalia
utue.personen.roh	Akmalova, Kristina
utue.personen.roh	Bryun, Evgeny
utue.personen.roh	Sychev, Dmitry
dcterms.isPartOf.ZSTitelID	Current Drug Metabolism	de_DE
dcterms.isPartOf.ZS-Issue	13	de_DE
dcterms.isPartOf.ZS-Volume	23	de_DE
utue.fakultaet	Universität Tübingen (ohne Fakultätsangabe)